(Total Views: 508)
Posted On: 04/22/2021 11:17:57 AM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Gilead & Remdesivir mentioned by a guest analyst on Fox Business just minutes ago. What was mentioned? 25 BILLION of cash on hand, interest in acquiring promising biotech properties, and issues with Remdesivir. I bet they aren't watching any active drug trials. That would be such a waste of time for them because they can just wait for "the market" to guide their business decisions.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)